| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1992PNAS...89.1750S |
| P356 | DOI | 10.1073/PNAS.89.5.1750 |
| P8608 | Fatcat ID | release_q7uoed6bubfxrcvmkm6eg2n6nm |
| P953 | full work available at URL | https://europepmc.org/articles/PMC48530 |
| https://europepmc.org/articles/PMC48530?pdf=render | ||
| P932 | PMC publication ID | 48530 |
| P698 | PubMed publication ID | 1542669 |
| P5875 | ResearchGate publication ID | 21612395 |
| P2093 | author name string | K. Harada | |
| F. Takaku | |||
| Y. Yazaki | |||
| M. Katsuki | |||
| T. Murase | |||
| N. Yamada | |||
| M. Shimada | |||
| H. Shimano | |||
| T. Gotoda | |||
| C. Fukazawa | |||
| P2860 | cites work | Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor | Q24297663 |
| Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins | Q24609758 | ||
| Apolipoprotein E: cholesterol transport protein with expanding role in cell biology | Q28294791 | ||
| Hepatic and renal expression of rat apolipoprotein E under control of the metallothionein promoter in transgenic mice | Q28565078 | ||
| A receptor-mediated pathway for cholesterol homeostasis | Q29616158 | ||
| Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits | Q33832739 | ||
| Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice | Q34175241 | ||
| Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors | Q34263181 | ||
| Abnormal in vivo metabolism of apolipoprotein E4 in humans | Q34539465 | ||
| Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits | Q34575925 | ||
| Complete nucleotide sequence of the gene encoding the rat apolipoprotein E | Q35059046 | ||
| Effect of low density lipoprotein receptor deficiency on the metabolism of apolipoprotein B-100 in blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits | Q35577426 | ||
| Metabolism of apolipoprotein B-100 in large very low density lipoproteins of blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits | Q35595098 | ||
| Metabolism of lipoproteins containing apolipoprotein B-100 in blood plasma of rabbits: heterogeneity related to the presence of apolipoprotein E. | Q35606300 | ||
| Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor | Q36299005 | ||
| Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits | Q36312775 | ||
| Rat apolipoprotein E mRNA. Cloning and sequencing of double-stranded cDNA | Q36591500 | ||
| Rate and equilibrium constants for binding of apo-E HDL c (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: Evidence for multiple receptor binding of apo-E HDL c | Q37330623 | ||
| Evolution of apolipoprotein E: mouse sequence and evidence for an 11-nucleotide ancestral unit | Q37556999 | ||
| Metallothionein | Q39740491 | ||
| The effect of apo E secretion on lipoprotein uptake in transfected cells | Q41656283 | ||
| Quantitative determination of serum triglycerides by the use of enzymes | Q43418524 | ||
| The enhanced cellular uptake of very-low-density lipoprotein enriched in apolipoprotein E | Q44935618 | ||
| Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity | Q46168707 | ||
| In the absence of a downstream element, the apolipoprotein E gene is expressed at high levels in kidneys of transgenic mice | Q46251735 | ||
| Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice | Q46507581 | ||
| Enhanced metabolism of normolipidemic human plasma very low density lipoprotein in cultured cells by exogenous apolipoprotein E-3 | Q67967629 | ||
| Apolipoprotein E polymorphism and atherosclerosis | Q68126635 | ||
| Accumulation of human apolipoprotein E in the plasma of transgenic mice | Q68905307 | ||
| Structure of the low-density lipoprotein receptor-related protein (LRP) promoter | Q69404071 | ||
| Measurement of apolipoprotein B radioactivity in whole blood plasma by precipitation with isopropanol | Q69644739 | ||
| Enzymatic determination of total serum cholesterol | Q69744405 | ||
| Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apoproteins | Q71302410 | ||
| Serum lipoprotein measurement--liquid chromatography and sequential floatation (ultracentrifugation) compared | Q71703822 | ||
| Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia | Q72060994 | ||
| The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E | Q72868797 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| hypercholesterolemia | Q762713 | ||
| overexpression | Q61643320 | ||
| P1104 | number of pages | 5 | |
| P304 | page(s) | 1750-1754 | |
| P577 | publication date | 1992-03-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia | |
| P478 | volume | 89 |
| Q37228000 | A human apolipoprotein E mimetic peptide reduces atherosclerosis in aged apolipoprotein E null mice |
| Q39442352 | A new recombinant human apolipoprotein E mimetic peptide with high-density lipoprotein binding and function enhancing activity |
| Q33242076 | ApoE plasma levels and risk of cardiovascular mortality in old age |
| Q44511121 | Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A. |
| Q74171232 | Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice |
| Q24318760 | Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase |
| Q35919265 | Apolipoprotein E-induced cell signaling in the vessel wall |
| Q34497951 | Apolipoprotein E: From lipid transport to neurobiology |
| Q44158115 | Arterial hardening in mice |
| Q28584877 | Characterization of the gene expression profile of heterozygous liver-specific glucokinase knockout mice at a young age |
| Q37383956 | Cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E. |
| Q33993678 | Current, new and future treatments in dyslipidaemia and atherosclerosis |
| Q33893953 | Detection of Apolipoprotein E Gene Polymorphism and Blood Lipid Level in Hemodialysis Patients |
| Q34137756 | Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice |
| Q77714412 | Effect of human apolipoprotein E isoforms on plasma lipids, lipoproteins and apolipoproteins in apolipoprotein E-deficient mice |
| Q43682775 | Effects of short-term treatment with corticotropin on the serum apolipoprotein pattern |
| Q56965460 | Fetal HDL/apoE: a novel regulator of gene expression in human placental endothelial cells |
| Q30661436 | Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty |
| Q37351939 | Genes and physiology: molecular physiology in genetically engineered animals |
| Q54575442 | Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein. |
| Q37381203 | Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. |
| Q45948223 | Hypolipidemic and hyperlipidemic phenotypes in transgenic mice expressing human apolipoprotein E2. |
| Q37381987 | Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma |
| Q34198863 | Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall |
| Q42061995 | Insight into lipid surface recognition and reversible conformational adaptations of an exchangeable apolipoprotein by multidimensional heteronuclear NMR techniques |
| Q34141163 | Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior |
| Q24563247 | Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes |
| Q77452740 | Lipoproteins and atherogenesis |
| Q40588222 | Lipoproteins and their functions |
| Q35765799 | Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice |
| Q40601689 | Molecular biology and gene transfer in atherosclerosis in the stenting era. |
| Q35043691 | Mouse models as tools for dissecting disorders of lipoprotein metabolism |
| Q46959635 | Murine mentors: transgenic and knockout models of surgical disease |
| Q37519955 | Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. |
| Q55333947 | Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics. |
| Q41021318 | Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B. |
| Q36434617 | Recent developments in the treatment of atherosclerosis |
| Q42443609 | Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms |
| Q71239660 | Regulation of the apolipoprotein E by dietary lipids occurs by transcriptional and post-transcriptional mechanisms |
| Q28378715 | Renal apolipoproteins in nephrotic rats |
| Q35108120 | S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease. |
| Q40336543 | Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice |
| Q35974993 | Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein |
| Q36559706 | Testis-specific expression of a metallothionein I-driven transgene correlates with undermethylation of the locus in testicular DNA. |
| Q41333505 | The human apolipoprotein E gene is negatively regulated in human liver HepG2 cells by the transcription factor BEF-1. |
| Q33213990 | The key role of apolipoprotein E in atherosclerosis |
| Q71860408 | Transcriptional regulation of apolipoprotein E expression by cyclic AMP |
| Q40781025 | Transgenic animals as models for human disease--report of an EC Study Group |
| Q36525382 | Transgenic mouse models of lipoprotein metabolism and atherosclerosis |
| Q41755840 | Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis |
| Q45872976 | Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA. |
| Q37288251 | Triptolide inhibits the progression of atherosclerosis in apolipoprotein E-/- mice |
| Q33902876 | Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E. |
| Q46632174 | USF1 and dyslipidemias: converging evidence for a functional intronic variant |
Search more.